# Glasgow Prognostic Score (GPS) and Tumor Response as Biomarkers of Nivolumab Monotherapy in Third- or Later-line Setting for Advanced Gastric Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/glasgow-prognostic-score-gps-and-tumor-response-as-biomarkers-of-nivolumab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Takashi Kurosaki,Hisato Kawakami,Seiichiro Mitani,Ryohei Kawabata,Takayuki Takahama,Yoshikane Nonagase,Soichi Fumita,Tomohiro Ozaki,Yasutaka Chiba,Takao Tamura,Kazuhiko Nakagawa |
| Citations | 21 |
| DOI | 10.21873/invivo.11989 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://iv.iiarjournals.org/content/invivo/34/4/1921.full.pdf |
| OpenAlex ID | https://openalex.org/W3040280880 |
| PMID | 32606164 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Soichi Fumita](https://scholariq.org/researchers/soichi-fumita/)

## Paper primary topic

- [Inflammatory Biomarkers in Disease Prognosis](https://scholariq.org/topics/inflammatory-biomarkers-in-disease-prognosis/)

## Paper topics

- [Inflammatory Biomarkers in Disease Prognosis](https://scholariq.org/topics/inflammatory-biomarkers-in-disease-prognosis/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.